标题
Role of myeloid-derived suppressor cells in metastasis
作者
关键词
-
出版物
CANCER AND METASTASIS REVIEWS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-07
DOI
10.1007/s10555-020-09947-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer Genome Evolutionary Trajectories in Metastasis
- (2020) Nicolai J. Birkbak et al. CANCER CELL
- Phase I dose‐escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer
- (2020) Takaaki Masuda et al. CANCER SCIENCE
- Paraneoplastic neutrophilic leukaemoid reaction in a patient with melanoma: association between tumour volume and leucocytosis
- (2020) L. Fredeau et al. BRITISH JOURNAL OF DERMATOLOGY
- A pilot study of Bruton’s tyrosine kinase inhibitor ibrutinib alone and in combination with PD-1 inhibitor nivolumab in patients with metastatic solid tumors.
- (2020) Brooke Benner et al. JOURNAL OF CLINICAL ONCOLOGY
- BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
- (2020) Bruno Bockorny et al. NATURE MEDICINE
- Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors
- (2020) Aohan Hou et al. Frontiers in Immunology
- Myeloid Cell-Derived Arginase in Cancer Immune Response
- (2020) Tomasz M. Grzywa et al. Frontiers in Immunology
- Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort
- (2020) Kyle G Mitchell et al. Journal for ImmunoTherapy of Cancer
- Ibrutinib in Gynecological Malignancies and Breast Cancer: A Systematic Review
- (2020) Julian Matthias Metzler et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Looking backward in time to define the chronology of metastasis
- (2020) Zheng Hu et al. Nature Communications
- Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine
- (2020) Mahmoud Mohammad Yaseen et al. Open Biology
- Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer
- (2019) Zhigang Ma et al. PATHOLOGY RESEARCH AND PRACTICE
- Monocyte heterogeneity and functions in cancer
- (2019) Claire E. Olingy et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Pembrolizumab versus the standard of care for cancer therapy: A meta-analysis of 12 KEYNOTE trials comparing overall survival.
- (2019) Nathaniel Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- O-002Ibrutinib in combination with nab-paclitaxel and gemcitabine as first-line treatment for patients with metastatic pancreatic adenocarcinoma: results from the phase 3 RESOLVE study
- (2019) M Tempero et al. ANNALS OF ONCOLOGY
- Quantitative evidence for early metastatic seeding in colorectal cancer
- (2019) Zheng Hu et al. NATURE GENETICS
- A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms
- (2019) Taymeyah Al-Toubah et al. NEUROENDOCRINOLOGY
- Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma
- (2019) Malgorzata Czystowska-Kuzmicz et al. Nature Communications
- Does early metastatic seeding occur in colorectal cancer?
- (2019) Alessandro Magrì et al. Nature Reviews Gastroenterology & Hepatology
- Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells
- (2019) Minjun C. Apodaca et al. Journal for ImmunoTherapy of Cancer
- Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors
- (2019) Marijo Bilusic et al. Journal for ImmunoTherapy of Cancer
- Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer
- (2019) Rana Jahanban-Esfahlan et al. Cancers
- 440OPhase I study of the arginase inhibitor INCB001158 (1158) alone and in combination with pembrolizumab (PEM) in patients (Pts) with advanced/metastatic (adv/met) solid tumours
- (2019) A Naing et al. ANNALS OF ONCOLOGY
- IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients
- (2019) Richard P. Tobin et al. Frontiers in Oncology
- p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy
- (2018) Nicola R. Hardwick et al. CLINICAL CANCER RESEARCH
- Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients
- (2018) Swati Khanna et al. CLINICAL CANCER RESEARCH
- A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer and Systemic Inflammation
- (2018) Giuseppe Giaccone et al. Clinical Lung Cancer
- Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis
- (2018) Chong Wu et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples
- (2018) David K. Edwards V et al. Oncotarget
- The Involvement of Arginase and Nitric Oxide Synthase in Breast Cancer Development: Arginase and NO Synthase as Therapeutic Targets in Cancer
- (2018) Nikolay Avtandilyan et al. Biomed Research International
- Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
- (2018) Rebekka Weber et al. Frontiers in Immunology
- Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
- (2018) Viktor Fleming et al. Frontiers in Immunology
- Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab
- (2018) Richard P. Tobin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The Anti-Inflammatory Effects of Vitamin D in Tumorigenesis
- (2018) Wei Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Myeloid-derived suppressor cells inhibit T cell activation through nitrating LCK in mouse cancers
- (2018) Shan Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
- (2018) Alice Tzeng et al. Targeted Oncology
- Tumor Killing by CD4+ T Cells Is Mediated via Induction of Inducible Nitric Oxide Synthase-Dependent Macrophage Cytotoxicity
- (2018) Marte Fauskanger et al. Frontiers in Immunology
- CSF1R inhibitors exhibit anti-tumor activity in acute myeloid leukemia by blocking paracrine signals from support cells
- (2018) David K. Edwards et al. BLOOD
- Dormancy in cancer
- (2018) Hiroko Endo et al. CANCER SCIENCE
- Immune regulation and anti-cancer activity by lipid inflammatory mediators
- (2018) Saraswoti Khadge et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Dormant tumour cells, their niches and the influence of immunity
- (2018) Erica T. Goddard et al. NATURE CELL BIOLOGY
- Circulating and disseminated tumor cells: harbingers or initiators of metastasis?
- (2017) Arko Dasgupta et al. Molecular Oncology
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- (2017) Hongchao Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
- (2017) Yago Pico de Coana et al. Oncotarget
- Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)
- (2017) Jessica C. Hassel et al. OncoImmunology
- Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
- (2017) Michael A. Cannarile et al. Journal for ImmunoTherapy of Cancer
- Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment
- (2017) Susanne M. Steggerda et al. Journal for ImmunoTherapy of Cancer
- Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration
- (2017) Joseph Markowitz et al. Scientific Reports
- Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment
- (2016) Andrew Stiff et al. CANCER RESEARCH
- Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen
- (2016) Emeric Limagne et al. CANCER RESEARCH
- L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
- (2016) Roger Geiger et al. CELL
- Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
- (2016) A. Martens et al. CLINICAL CANCER RESEARCH
- Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer
- (2016) Emma Eriksson et al. Journal of Translational Medicine
- Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
- (2016) Olivier De Henau et al. NATURE
- Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma
- (2016) Robert J. Motzer et al. ONCOLOGIST
- G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers
- (2016) Wenbin Li et al. Protein & Cell
- Improving cancer immunotherapy by targeting the STATe of MDSCs
- (2016) Nienke de Haas et al. OncoImmunology
- JAK1/2 inhibition impairs T cell functionin vitroand in patients with myeloproliferative neoplasms
- (2015) Sowmya Parampalli Yajnanarayana et al. BRITISH JOURNAL OF HAEMATOLOGY
- Granulocytic myeloid-derived suppressor cells inversely correlate with plasma arginine and overall survival in critically ill patients
- (2015) A. Gey et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
- (2015) J. A. Califano et al. CLINICAL CANCER RESEARCH
- Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
- (2015) C. Gebhardt et al. CLINICAL CANCER RESEARCH
- Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy
- (2015) H.-M. Chen et al. CLINICAL CANCER RESEARCH
- Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
- (2015) Herbert I. Hurwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Mathematical models of the steps involved in the systemic delivery of a chemotherapeutic to a solid tumor: From circulation to survival
- (2015) Martin B. Ulmschneider et al. JOURNAL OF CONTROLLED RELEASE
- Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
- (2015) Nicholas Butowski et al. NEURO-ONCOLOGY
- Modulation of the tumor vasculature and oxygenation to improve therapy
- (2015) Dietmar W. Siemann et al. PHARMACOLOGY & THERAPEUTICS
- Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy
- (2014) Yago Pico de Coaña et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adverse Immunoregulatory Effects of 5FU and CPT11 Chemotherapy on Myeloid-Derived Suppressor Cells and Colorectal Cancer Outcomes
- (2014) J. Kanterman et al. CANCER RESEARCH
- Metastases in Immune-Mediated Dormancy: A New Opportunity for Targeting Cancer
- (2014) I. Romero et al. CANCER RESEARCH
- Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma
- (2014) D. T. Weed et al. CLINICAL CANCER RESEARCH
- Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration
- (2014) E. K. Bartlett et al. CLINICAL CANCER RESEARCH
- The HER2 peptide nelipepimut-S (E75) vaccine (NeuVax™) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response
- (2014) Erika J Schneble et al. Immunotherapy
- Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
- (2014) Robert Coleman et al. LANCET ONCOLOGY
- Metastatic sites and survival in lung cancer
- (2014) M. Riihimäki et al. LUNG CANCER
- Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
- (2014) S. L. Highfill et al. Science Translational Medicine
- Adjuvants and myeloid-derived suppressor cells: Enemies or allies in therapeutic cancer vaccination
- (2014) Audry Fernández et al. Human Vaccines & Immunotherapeutics
- Targeting Immune Suppression with PDE5 Inhibition in End-Stage Multiple Myeloma
- (2014) K. A. Noonan et al. Cancer Immunology Research
- The pre-metastatic niche: finding common ground
- (2013) Jaclyn Sceneay et al. CANCER AND METASTASIS REVIEWS
- The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer
- (2013) Nicola E. Annels et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
- (2013) Christiane Meyer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production
- (2013) Y. P. de Coana et al. Cancer Immunology Research
- Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
- (2013) Robert Wesolowski et al. Journal for ImmunoTherapy of Cancer
- The metastatic niche and stromal progression
- (2012) Jonathan P. Sleeman CANCER AND METASTASIS REVIEWS
- Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth
- (2012) Matthew R. Porembka et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology
- (2012) Claudia A. Dumitru et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Metabolism of L-Arginine by Myeloid-Derived Suppressor Cells in Cancer: Mechanisms of T cell suppression and Therapeutic Perspectives
- (2012) Patrick Raber et al. IMMUNOLOGICAL INVESTIGATIONS
- The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
- (2012) Dennis Lindau et al. IMMUNOLOGY
- Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer
- (2012) Sokratis Trellakis et al. Innate Immunity
- Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples
- (2012) Athanasios Kotsakis et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins
- (2012) L. Wang et al. JOURNAL OF IMMUNOLOGY
- Tumor-Expressed Inducible Nitric Oxide Synthase Controls Induction of Functional Myeloid-Derived Suppressor Cells through Modulation of Vascular Endothelial Growth Factor Release
- (2012) P. Jayaraman et al. JOURNAL OF IMMUNOLOGY
- Differential Immunologic and MicroRNA Effects of 2 Dosing Regimens of Recombinant Human Granulocyte/Macrophage Colony Stimulating Factor
- (2012) Pierre L. Triozzi et al. JOURNAL OF IMMUNOTHERAPY
- Origins of tumor-associated macrophages and neutrophils
- (2012) V. Cortez-Retamozo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Many mechanisms mediating mobilization: an alliterative review
- (2011) Jonathan Hoggatt et al. CURRENT OPINION IN HEMATOLOGY
- MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
- (2011) James Finke et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ
- (2011) Nicole Sänger et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor-induced changes in the phenotype of blood-derived and tumor-associated T cells of early stage breast cancer patients
- (2011) I. Poschke et al. INTERNATIONAL JOURNAL OF CANCER
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy
- (2010) Stephanie L. Hines et al. BREAST
- Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
- (2010) Isabel Poschke et al. CANCER RESEARCH
- AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
- (2010) J. E. Talmadge et al. CANCER RESEARCH
- INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect
- (2010) Alberto A Chiappori et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Use of α,25-Dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma
- (2010) Jarrett E. Walsh et al. HUMAN IMMUNOLOGY
- Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
- (2010) S. Nagaraj et al. JOURNAL OF IMMUNOLOGY
- Arginase I–Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
- (2009) Paulo C. Rodriguez et al. CANCER RESEARCH
- Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
- (2009) J. S. Ko et al. CLINICAL CANCER RESEARCH
- Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
- (2009) C. A. Corzo et al. JOURNAL OF IMMUNOLOGY
- The critical role of the bone microenvironment in cancer metastases
- (2009) Sandra Casimiro et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Direct Genetic Analysis of Single Disseminated Cancer Cells for Prediction of Outcome and Therapy Selection in Esophageal Cancer
- (2008) Nikolas H. Stoecklein et al. CANCER CELL
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Splenic metastases—not a frequent problem, but an underestimate location of metastases: epidemiology and course
- (2008) Jörg Sauer et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Comparative lesion sequencing provides insights into tumor evolution
- (2008) S. Jones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now